Ada Patient Finder -- Daily Briefing

Saturday, February 07, 2026 -- 8:31 AM ET
Snapshot: 2026-02-06
Pipeline Snapshot
€97,588,666
Total Pipeline (Unweighted)
€7,951,386
Weighted Pipeline
135
Open Opps
€0
Closing This Quarter
2
Calls Yesterday
2.1
7-Day Avg Calls
27
Stale Deals
Stage Moves (Last 24h)
No stage changes in the last 24 hours
Pipeline Changes
No pipeline changes
Stale Deals (14+ Days Since Last Contact)
Crohns Colitis Foundation 372d No Contact
Jacob Plummer | Qualification | 5% | €424,569
Ontario Enhancements - Suicide Pop Up - Delivery 262d No Contact
Simon Wolpert | Qualification | 5% | €247,705
Ontario SOW9 - Health Care Connect (Primary Care Attachment) - Planning Only 202d No Contact
Simon Wolpert | Proposal | 30% | €30,963
Astrazeneca - Wainua 155d No Contact
Usaid Cheema | Qualification | 5% | €500,000
Walgreens/Boots 151d No Contact
Randal Whitmore | Qualification | 5% | €424,569
Patient Finder for Temple Health 150d No Contact
Randal Whitmore | Qualification | 5% | €424,569
Health 811 SOW9 - HCC + Survey Planning + Delivery 143d No Contact
Simon Wolpert | Proposal | 30% | €92,889
DKV Seguros 137d No Contact
Johannes Vonhuelsen | Discovery | 10% | €486,000
GSK - Shingrix 121d No Contact
Usaid Cheema | Qualification | 5% | €424,569
Alberta Health Services - Patient Portal (via Orion & Telus/IBM) 90d No Contact
Simon Wolpert | Qualification | 5% | €4,799,302
+17 more stale deals
No Decision Maker Engaged
AbbVie - Botox No DM
Usaid Cheema | Qualification | 5% | €424,569
AbbVie - Rinvoq No DM
Usaid Cheema | Qualification | 5% | €424,569
AbbVie - Vraylar No DM
Usaid Cheema | Qualification | 5% | €500,000
ACADIA Pharmaceuticals | Daybue | Rett syndrome No DM
Usaid Cheema | Qualification | 5% | €424,569
Acorda Therapeutics | Ampyra | Multiple sclerosis (improve walking) No DM
Usaid Cheema | Qualification | 5% | €424,569
Aetna a CVS Health Company No DM
Simon Wolpert | Qualification | 5% | €254,741
Alberta Health Services - Patient Portal (via Orion & Telus/IBM) No DM
Simon Wolpert | Qualification | 5% | €4,799,302
Alkermes - Libalvi No DM
Usaid Cheema | Qualification | 5% | €500,000
+20 more
Flagged Calls (< 3.0)
No flagged calls
Calls Yesterday (2)
API - status update 27m
Participants:
Social Check-in 48m
Participants:
Top Deals by Value
GNAL
Qualification | 5%
€20,500,000
Biogen | Friedreichs Ataxia | Global - Phase 2
Qualification | 5%
€6,000,000
Blue Shield of California
Proposal | 30%
€5,519,403
Alberta Health Services - Patient Portal (via Orion & Telus/IBM)
Qualification | 5%
€4,799,302
Resmed Phase 2
Qualification | 5%
€2,547,417
SANOFI | Diabetes | TZIELD | US - Phase 2
Discovery | 10%
€2,547,417
Biogen Germany FA extension
Discovery | 10%
€2,100,000
Blue Cross Blue Shield Arizona
Qualification | 5%
€1,443,536
Meetings Today
No meetings scheduled
System Health
Cron Jobs0 active
Background Tasks✓ healthy